A
Arad Ltd
TASE:ARD
Arad Ltd
TASE:ARD
Price:
4 675
ILS
-1.37%
Market Closed
Market Cap:
₪1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Arad Ltd
TASE:ARD
|
IL |
|
Phoenix Biotech Acquisition Corp
NASDAQ:CERO
|
US |
|
Columbus A/S
CSE:COLUM
|
DK |
Balance Sheet
Balance Sheet Decomposition
Arad Ltd
Arad Ltd
Balance Sheet Decomposition is not available for
Arad Ltd
Arad Ltd
Balance Sheet
Arad Ltd
Arad Ltd
Currency: USD
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
3
|
15
|
4
|
2
|
11
|
7
|
3
|
5
|
9
|
7
|
9
|
17
|
19
|
13
|
17
|
14
|
18
|
29
|
32
|
17
|
14
|
18
|
|
| Cash Equivalents |
3
|
15
|
4
|
2
|
11
|
7
|
3
|
5
|
9
|
7
|
9
|
17
|
19
|
13
|
17
|
14
|
18
|
29
|
32
|
17
|
14
|
18
|
|
| Short-Term Investments |
0
|
0
|
7
|
6
|
7
|
7
|
8
|
9
|
7
|
8
|
8
|
8
|
8
|
9
|
13
|
5
|
6
|
7
|
7
|
0
|
0
|
0
|
|
| Total Receivables |
15
|
17
|
19
|
21
|
25
|
27
|
34
|
31
|
31
|
37
|
44
|
36
|
38
|
46
|
47
|
63
|
69
|
65
|
68
|
80
|
77
|
86
|
|
| Accounts Receivables |
15
|
17
|
19
|
21
|
25
|
26
|
34
|
30
|
31
|
36
|
42
|
34
|
35
|
43
|
44
|
59
|
63
|
62
|
64
|
73
|
69
|
79
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
6
|
3
|
4
|
7
|
8
|
8
|
|
| Inventory |
13
|
16
|
18
|
28
|
32
|
32
|
33
|
42
|
39
|
42
|
48
|
53
|
56
|
56
|
60
|
86
|
95
|
96
|
95
|
135
|
158
|
150
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
6
|
|
| Total Current Assets |
31
|
48
|
48
|
57
|
75
|
72
|
78
|
88
|
87
|
95
|
110
|
115
|
121
|
125
|
139
|
170
|
189
|
200
|
206
|
234
|
253
|
259
|
|
| PP&E Net |
9
|
12
|
11
|
13
|
14
|
14
|
15
|
15
|
17
|
18
|
18
|
21
|
21
|
22
|
24
|
28
|
48
|
45
|
43
|
51
|
62
|
63
|
|
| PP&E Gross |
9
|
12
|
11
|
13
|
14
|
14
|
15
|
15
|
17
|
18
|
18
|
21
|
21
|
22
|
24
|
28
|
48
|
45
|
43
|
51
|
62
|
63
|
|
| Accumulated Depreciation |
27
|
28
|
23
|
26
|
32
|
25
|
23
|
25
|
27
|
30
|
33
|
32
|
35
|
38
|
43
|
50
|
48
|
53
|
53
|
56
|
64
|
65
|
|
| Intangible Assets |
0
|
1
|
1
|
0
|
2
|
2
|
11
|
10
|
9
|
9
|
9
|
10
|
8
|
7
|
7
|
12
|
17
|
16
|
14
|
11
|
10
|
8
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
6
|
4
|
4
|
6
|
4
|
4
|
4
|
14
|
12
|
13
|
12
|
12
|
12
|
11
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
4
|
4
|
3
|
3
|
5
|
8
|
6
|
6
|
8
|
6
|
5
|
5
|
7
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
4
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
5
|
5
|
6
|
3
|
4
|
4
|
4
|
6
|
6
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
6
|
4
|
4
|
6
|
4
|
4
|
4
|
14
|
12
|
13
|
12
|
12
|
12
|
11
|
|
| Total Assets |
40
N/A
|
61
+50%
|
60
-2%
|
71
+18%
|
93
+31%
|
94
+1%
|
117
+24%
|
125
+7%
|
125
+0%
|
132
+6%
|
149
+13%
|
159
+7%
|
162
+2%
|
169
+4%
|
186
+10%
|
236
+27%
|
275
+17%
|
286
+4%
|
285
0%
|
318
+11%
|
348
+9%
|
354
+2%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
12
|
14
|
15
|
19
|
23
|
17
|
20
|
21
|
20
|
16
|
22
|
18
|
19
|
22
|
27
|
39
|
39
|
37
|
40
|
61
|
53
|
52
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
9
|
9
|
10
|
11
|
14
|
11
|
15
|
16
|
19
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
2
|
2
|
2
|
4
|
11
|
15
|
6
|
21
|
24
|
26
|
|
| Current Portion of Long-Term Debt |
13
|
9
|
6
|
8
|
8
|
8
|
8
|
13
|
12
|
6
|
7
|
8
|
8
|
8
|
10
|
13
|
14
|
15
|
15
|
16
|
21
|
21
|
|
| Other Current Liabilities |
0
|
0
|
0
|
3
|
0
|
6
|
5
|
6
|
6
|
19
|
9
|
9
|
10
|
10
|
18
|
21
|
17
|
17
|
29
|
18
|
21
|
22
|
|
| Total Current Liabilities |
25
|
22
|
21
|
30
|
31
|
31
|
33
|
40
|
37
|
44
|
48
|
46
|
49
|
50
|
66
|
88
|
94
|
95
|
104
|
132
|
139
|
140
|
|
| Long-Term Debt |
9
|
10
|
9
|
8
|
9
|
11
|
16
|
13
|
12
|
12
|
14
|
18
|
16
|
16
|
17
|
28
|
44
|
42
|
39
|
41
|
46
|
45
|
|
| Deferred Income Tax |
0
|
1
|
0
|
1
|
1
|
0
|
3
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
4
|
4
|
3
|
2
|
2
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
7
|
7
|
5
|
1
|
3
|
10
|
9
|
7
|
1
|
0
|
6
|
4
|
4
|
4
|
9
|
13
|
15
|
3
|
3
|
3
|
3
|
|
| Total Liabilities |
34
N/A
|
40
+16%
|
37
-7%
|
44
+17%
|
42
-4%
|
44
+6%
|
61
+37%
|
64
+5%
|
59
-7%
|
60
+0%
|
64
+8%
|
71
+10%
|
71
-1%
|
71
+0%
|
88
+24%
|
128
+46%
|
157
+22%
|
156
-1%
|
150
-4%
|
179
+20%
|
191
+7%
|
191
0%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
7
|
7
|
7
|
8
|
8
|
8
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
1
|
4
|
7
|
9
|
19
|
27
|
29
|
34
|
39
|
46
|
54
|
57
|
67
|
75
|
73
|
83
|
93
|
99
|
102
|
106
|
130
|
143
|
|
| Additional Paid In Capital |
0
|
9
|
8
|
9
|
24
|
29
|
26
|
26
|
26
|
26
|
29
|
29
|
29
|
29
|
29
|
29
|
32
|
32
|
32
|
32
|
34
|
34
|
|
| Other Equity |
0
|
1
|
1
|
1
|
0
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
8
|
5
|
6
|
7
|
2
|
0
|
0
|
8
|
14
|
|
| Total Equity |
6
N/A
|
21
+237%
|
22
+7%
|
27
+21%
|
51
+89%
|
49
-3%
|
56
+13%
|
61
+9%
|
66
+8%
|
73
+11%
|
84
+16%
|
88
+4%
|
92
+4%
|
98
+7%
|
98
+1%
|
107
+9%
|
119
+10%
|
130
+10%
|
136
+4%
|
139
+2%
|
157
+13%
|
163
+4%
|
|
| Total Liabilities & Equity |
40
N/A
|
61
+50%
|
60
-2%
|
71
+18%
|
93
+31%
|
94
+1%
|
117
+24%
|
125
+7%
|
125
+0%
|
132
+6%
|
149
+13%
|
159
+7%
|
162
+2%
|
169
+4%
|
186
+10%
|
236
+27%
|
275
+17%
|
286
+4%
|
285
0%
|
318
+11%
|
348
+9%
|
354
+2%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
17
|
20
|
20
|
20
|
23
|
24
|
24
|
24
|
24
|
24
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
